Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Hemagen Diagnostics is a biotechnology company that develops, manufactures, and markets medical diagnostic test kits and clinical chemistry analyzers for human and veterinary applications. Founded in 1985 and headquartered in Columbia, Maryland, the company is recognized for its VIRGO line of immunoassays, which utilize ELISA, immunofluorescence (IFA), and hemagglutination (HA) technologies to diagnose autoimmune and infectious diseases. Hemagen also offers the Analyst benchtop clinical chemistry system, a proprietary centrifugal analyzer used in physician offices and veterinary clinics worldwide. The company maintains a significant international presence through its wholly-owned Brazilian subsidiary, Hemagen Diagnósticos, which serves the South American market.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Hemagen Diagnósticos.